Article medicale Tunisie, Article medicale Amplatzer septal occluder ; congenital ; device closure ; ventricular septal defect la tunisie medicale, la tunisie medicale Transcatheter closure of congenital ventricular septal defects using the Amplatzer Duct Occluder II device: preliminary data from a Tunisian monocentric study Mehdi Slim, Sameh Ben Farhat, Sami Ben Ouannes, Raoudha Chrigui, Faten Yahia, Houceme Thabet, Houda Ghardallou, Rym Gribaa, Aymen ElHraiech, Elies Neffati La tunisie Medicale - 2022 ; Vol 100 ( n°06 ) : 450-454 [ 64 times seen ] First Name : * Last Name : * Your E-mail : * E-mail friend 1 : E-mail friend 2 : E-mail friend 3 : E-mail friend 4 : E-mail friend 5 : Comment : ( * Required fields ) Login or register now E-mail : Password : If you forgot your password : click here Summary Introduction: Percutaneous closure of congenital ventricular septal defects (VSDs) represents a promising alternative to surgery with lower rate of complications and shorter hospital stay. Its main limitation is the choice of the appropriate device for each type of defect. Aim: To report the experience of the service of cardiology (Sahloul hospital, Sousse, Tunisia) in percutaneous closure of congenital VSDs with Amplatzer Duct Occluder II (ADOII). Methods: This was a retrospective, monocentric study, conducted from January 2013 to December 2017. The study included patients treated by percutaneous closure of congenital VSDs with the ADOII device. Results: Twelve patients (6 boys; 6 girls) were included. The mean±SD of patients’ age and weight were 65±41 months and 23±10 kg, respectively. VSDs were peri-membranous (n=9) and muscular (n=3), and defects were restrictive (n=11) and non-restrictive (n=1). The mean (minimum-maximum) size of VSDs was 4.72 (3-6) mm. Eleven ADOII prostheses were successfully implanted. One failure procedure was noted with migration of the device into the pulmonary artery. A second child with perimembranous defect developed transient atrioventricular block. No deaths occurred. Conclusion.: The present early experience shows that percutaneous closure with ADOII device of perimembranous and trabecular VSDs is safe and effective. Key - Words Amplatzer septal occluder ; congenital ; device closure ; ventricular septal defect Article Reference Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation. 1988 Aug;78(2):361–8. DOI: 10.1161/01.cir.78.2.361 Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, Zarayelyan AG. Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children. J Am Coll Cardiol. 1999 Apr;33(5):1395– 9. DOI: 10.1016/s0735-1097(99)00011-x Janorkar S, Goh T, Wilkinson J. Transcatheter closure of ventricular septal defects using the Rashkind device: initial experience. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 1999 Jan;46(1):43–8. DOI: 10.1002/(SICI)1522- 726X(199901)46:1<43::AID-CCD12>3.0.CO;2-T Sideris EB, Walsh KP, Haddad JL, Chen CR, Ren SG, Kulkarni H. Occlusion of congenital ventricular septal defects by the buttoned device. “Buttoned device” Clinical Trials International Register. Heart Br Card Soc. 1997 Mar;77(3):276–9. DOI: 10.1136/hrt.77.3.276 Bridges ND, Perry SB, Keane JF, Goldstein SAN, Mandell V, Mayer JE, et al. Preoperative Transcatheter Closure of Congenital Muscular Ventricular Septal Defects. N Engl J Med. 1991 May 9;324(19):1312–7. DOI: 10.1056/NEJM199105093241903 Knauth AL, Lock JE, Perry SB, McElhinney DB, Gauvreau K, Landzberg MJ, et al. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation. 2004 Aug 3;110(5):501–7. DOI: 10.1161/01. CIR.0000137116.12176.A6 Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J. 2007 Oct;28(19):2361–8. DOI: 10.1093/eurheartj/ehm314 Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects. State of the art. J Cardiovasc Med Hagerstown Md. 2007 Jan;8(1):39–45. DOI: 10.2459/01. JCM.0000247434.59451.d7 Carminati M, Butera G, Chessa M, Drago M, Negura D, Piazza L. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol. 2005 Dec 19;96(12A):52L-58L. DOI: 10.1016/j.amjcard.2005.09.068 Butera G, Piazza L, Saracino A, Chessa M, Carminati M. Transcatheter Closure of Membranous Ventricular Septal Defects-Old Problems and New Solutions. Interv Cardiol Clin. 2013 Jan;2(1):85–91. DOI: 10.1016/j.iccl.2012.09.003 Yang L, Tai B-C, Khin LW, Quek SC. A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD). J Intervent Cardiol. 2014 Jun;27(3):260– 72. DOI: 10.1111/joic.12121 Santhanam H, Yang L, Chen Z, Tai B-C, Rajgor DD, Quek S-C. A meta-analysis of transcatheter device closure of perimembranous ventricular septal defect. Int J Cardiol. 2018 01;254:75–83. DOI: 10.1016/j.ijcard.2017.12.011 . Cinteză EE, Butera G. Complex ventricular septal defects. Update on percutaneous closure. Romanian J Morphol Embryol Rev Roum Morphol Embryol. 2016;57(4):1195–205. DOI: 10.1016/S1885-5857(06)60177-1 Narin N, Baykan A, Pamukcu O, Argun M, Ozyurt A, Mese T, et al. ADO II in Percutaneous VSD Closure in Pediatric Patients. J Intervent Cardiol. 2015 Oct;28(5):479–84. DOI: 10.1111/joic.12222 Fischer G, Apostolopoulou SC, Rammos S, Schneider MB, Bjørnstad PG, Kramer HH. The Amplatzer Membranous VSD Occluder and the vulnerability of the atrioventricular conduction system. Cardiol Young. 2007 Oct;17(5):499–504. DOI: 10.1017/S1047951107000984 Predescu D, Chaturvedi RR, Friedberg MK, Benson LN, Ozawa A, Lee K-J. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg. 2008 Nov;136(5):1223–8. • DOI: 10.1016/j.jtcvs.2008.02.037 Bentham JR, Gujral A, Adwani S, Archer N, Wilson N. Does the technique of interventional closure of perimembranous ventricular septal defect reduce the incidence of heart block? Cardiol Young. 2011 Jun;21(3):271–80. DOI: 10.1017/S1047951110002039 Vijayalakshmi IB, Narasimhan C, Singh B, Manjunath CN. Treatment of congenital non-ductal shunt lesions with the amplatzer duct occluder II. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2017 May;89(6):E185–93. DOI: 10.1002/ccd.25250 Ovaert C, Kammache I, Bonello B, Habib G, Fraisse A. Occlusion percutanée des communications intercardiaques. Arch Cardiovasc Dis Suppl. 2011 Jun 1;3(2):154–62. DOI: 10.1016/ S1878-6480(11)70346-9 El Tahlawi M, Kammache I, Fraisse A. Ventricular septal defect closure in a small children with the Amplatzer Duct Occluder II. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2011 Feb 1;77(2):268–71. DOI: 10.1002/ccd.22723 Tan CA, Levi DS, Moore JW. Percutaneous closure of perimembranous ventricular septal defect associated with a ventricular septal aneurysm using the Amplatzer ductal occluder. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2005 Nov;66(3):427–31. DOI: 10.1002/ccd.20499 Dilawar M, Numan M, El-Sisi A, Gendi SM, Ahmad Z. Percutaneous closure of ventricular septal defect associated with tunnel-shaped aneurysm using the Amplatzer duct occluder. Pediatr Cardiol. 2008 Mar;29(2):366–70. DOI: 10.1007/s00246-007-9092-0 Kanaan M, Ewert P, Berger F, Assa S, Schubert S. Follow-up of patients with interventional closure of ventricular septal defects with Amplatzer Duct Occluder II. Pediatr Cardiol. 2015 Feb;36(2):379–85. DOI: 10.1007/s00246-014-1017-0 First Name : * Last Name : * : * E-mail friend 1 : E-mail friend 2 : E-mail friend 3 : E-mail friend 4 : E-mail friend 5 : Comment : ( * Required fields ) Login or register now E-mail : Password : If you forgot your password : click here Login E-mail : Password : Remember Me Forgot password? Sign UP Archives 2022 January February March April May June July August September October November December See all archives Keywords most used Tunisia treatment Child surgery diagnosis prognosis Children epidemiology Crohn’s disease Risk factors Breast cancer Cancer screening obesity Ulcerative colitis Newsletter Sign up to receive our newsletter E-mail : Stay in Touch Join Us! ! ©2011 LA TUNISIE MEDICALE. All rights reserved. Creation site web tunisie Home // About // Current Issue // Advanced Search // Journal Archives // Instruction for Authors Subscription // Contact